🇺🇸 FDA
Patent

US 10137104

Combination therapy with an anti-hyaluronan agent and therapeutic agent

granted A61KA61K31/337A61K31/37

Quick answer

US patent 10137104 (Combination therapy with an anti-hyaluronan agent and therapeutic agent) held by HALOZYME, INC. expires Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
HALOZYME, INC.
Grant date
Tue Nov 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/337, A61K31/37, A61K31/42, A61K31/56